| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5280409
Max Phase: Preclinical
Molecular Formula: C17H18N4O
Molecular Weight: 294.36
Associated Items:
Representations
Canonical SMILES: N[C@H](Cc1c[nH]cn1)C(=O)NCc1ccc2ccccc2c1
Standard InChI: InChI=1S/C17H18N4O/c18-16(8-15-10-19-11-21-15)17(22)20-9-12-5-6-13-3-1-2-4-14(13)7-12/h1-7,10-11,16H,8-9,18H2,(H,19,21)(H,20,22)/t16-/m1/s1
Standard InChI Key: PLHYVMRZZZJNDB-MRXNPFEDSA-N
Associated Targets(non-human)
Nln Neurolysin, mitochondrial (179 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 294.36 | Molecular Weight (Monoisotopic): 294.1481 | AlogP: 1.75 | #Rotatable Bonds: 5 |
| Polar Surface Area: 83.80 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.09 | CX Basic pKa: 7.84 | CX LogP: 1.12 | CX LogD: 0.54 |
| Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.67 | Np Likeness Score: -0.51 |
References
| 1. Rahman MS, Kumari S, Esfahani SH, Nozohouri S, Jayaraman S, Kinarivala N, Kocot J, Baez A, Farris D, Abbruscato TJ, Karamyan VT, Trippier PC.. (2021) Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability., 64 (17.0): [PMID:34436882] [10.1021/acs.jmedchem.1c00759] |
Source
Source(1):